{"ticker": {"uuid": "3455c0f6-a0fb-4198-942a-77c63e1989a5", "symbol": "2511", "name": "HighTide Therapeutics, Inc.", "exchange": "HKG", "country": "HK", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "HighTide Therapeutics advances HTD1801 commercialization after NEJM Evidence recognition", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1wFBVV95cUxNdkEyWVZaVFZaMkYtcEYwTU5SaG5BMGhxV0p4TUtXVkhKQlpRTDU4TFJFS0NWMHpGR1FQd0t2NW9iUnBTX21lQnh1UWxGYjlZa2J0TG5HUjVSYkJXSFpQYlktSExjSnljaDJ3aWpkTFVxS2hGcVllY1BtYTFUV2x6Q09LRDc1bWpNLTFwN2Jlb1RtMGhJd2NZcDZpN1ZlODdZQ1RBdXZNZkx5OVJVSTdTck5NWHlhc1B5Ynd4MmI5bTVaZmZLZ0VxVGxUbk5wSnRMU3g2dEc2UQ?oc=5", "source_name": "TipRanks", "published_at": "2026-07-10T11:43:27+00:00", "published_display": "10 Jul 2026 11:43", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hightide wins China NDA acceptance for oral metabolic therapy", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxPTERIcVFfTmN1S0NYVlliY1lTaHVKbUdmemp0RkpZOHBCTDN0NEEwdHhjbDludkxUU29hMnZ6ejhTOElKejU3dnUxNVp0dTlJS2tPM21DQmpkN3JrRkhudEU1T2ptMU1VR25kM1JsTTlJUGJjOTVJelhwOFkyMXNZZkRzQmw1NlJQekg5TlZ0UF9NcEhwbzhsaTJQMXIzUmNWNTV1MA?oc=5", "source_name": "BioWorld News", "published_at": "2026-03-11T07:00:00+00:00", "published_display": "11 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HKSTP Applauds HighTide Therapeutics' IPO and Clinical Trial Milestone | HKSTP", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxPcDBNaWttTlhIYU9VeDEwRmZJYkxOX0E4SXc4dUx6VTVDcDAwalhibkFWM2JjS2JIS0dsaU5ib1h1bVRHMlkzeVJ4RW5MN2duTGdsNUswTDA5ZXV6WGp3VVRTQUNNU1Y1WEluMTNITkt2dWJHS0duQWtQMFZ2VVptaldsbWJZVDlsUnhZV0JVTzlHVDV6U2dJZnRfcE1wTko4NFVjei0yUjlXalNIOVhfcllvR0VrVllCZkFNTXpDYUR5VDdYalRzeUtEV0FFSFg1NWRHTGFiOHBqVEhwX1lSejAtT2U?oc=5", "source_name": "Hong Kong Science & Technology Parks Corporation", "published_at": "2023-12-27T08:00:00+00:00", "published_display": "27 Dec 2023 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "HighTide Therapeutics advances HTD1801 commercialization after NEJM Evidence recognition", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1wFBVV95cUxNdkEyWVZaVFZaMkYtcEYwTU5SaG5BMGhxV0p4TUtXVkhKQlpRTDU4TFJFS0NWMHpGR1FQd0t2NW9iUnBTX21lQnh1UWxGYjlZa2J0TG5HUjVSYkJXSFpQYlktSExjSnljaDJ3aWpkTFVxS2hGcVllY1BtYTFUV2x6Q09LRDc1bWpNLTFwN2Jlb1RtMGhJd2NZcDZpN1ZlODdZQ1RBdXZNZkx5OVJVSTdTck5NWHlhc1B5Ynd4MmI5bTVaZmZLZ0VxVGxUbk5wSnRMU3g2dEc2UQ?oc=5", "source_name": "TipRanks", "published_at": "2026-07-10T11:43:27+00:00", "published_display": "10 Jul 2026 11:43", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hightide wins China NDA acceptance for oral metabolic therapy", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxPTERIcVFfTmN1S0NYVlliY1lTaHVKbUdmemp0RkpZOHBCTDN0NEEwdHhjbDludkxUU29hMnZ6ejhTOElKejU3dnUxNVp0dTlJS2tPM21DQmpkN3JrRkhudEU1T2ptMU1VR25kM1JsTTlJUGJjOTVJelhwOFkyMXNZZkRzQmw1NlJQekg5TlZ0UF9NcEhwbzhsaTJQMXIzUmNWNTV1MA?oc=5", "source_name": "BioWorld News", "published_at": "2026-03-11T07:00:00+00:00", "published_display": "11 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HKSTP Applauds HighTide Therapeutics' IPO and Clinical Trial Milestone | HKSTP", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxPcDBNaWttTlhIYU9VeDEwRmZJYkxOX0E4SXc4dUx6VTVDcDAwalhibkFWM2JjS2JIS0dsaU5ib1h1bVRHMlkzeVJ4RW5MN2duTGdsNUswTDA5ZXV6WGp3VVRTQUNNU1Y1WEluMTNITkt2dWJHS0duQWtQMFZ2VVptaldsbWJZVDlsUnhZV0JVTzlHVDV6U2dJZnRfcE1wTko4NFVjei0yUjlXalNIOVhfcllvR0VrVllCZkFNTXpDYUR5VDdYalRzeUtEV0FFSFg1NWRHTGFiOHBqVEhwX1lSejAtT2U?oc=5", "source_name": "Hong Kong Science & Technology Parks Corporation", "published_at": "2023-12-27T08:00:00+00:00", "published_display": "27 Dec 2023 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 72, "total_relevant": 3, "sentiment_summary": {"positive": 0, "negative": 0, "neutral": 3, "score": 50, "total": 3, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 78, "events": [{"event": "general", "label": "Market update", "weight": 1.65, "count": 3}], "positive_events": 0, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 2.63, "latest_week": "2026-07-10", "one_week_move": -4.0, "four_week_move": -8.0, "twelve_week_move": -31.5, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.785389, "market_dynamics_buy_signal": false, "relative_strength": -12.72753, "fair_value_gap": -25.2, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 41.813, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-4.0% over one week, -8.0% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 57, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "TipRanks", "count": 1}, {"label": "BioWorld News", "count": 1}, {"label": "Hong Kong Science & Technology Parks Corporation", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 3}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 3}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "78/100 classification confidence."}, {"label": "Company focus", "value": "3", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-4.0% over one week, -8.0% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "HighTide Therapeutics advances HTD1801 commercialization after NEJM Evidence recognition"}], "updated_at": "2026-07-18T04:23:31.366610+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}